PMS-PIROXICAM CAPSULE

Země: Kanada

Jazyk: angličtina

Zdroj: Health Canada

Koupit nyní

Aktivní složka:

PIROXICAM

Dostupné s:

PHARMASCIENCE INC

ATC kód:

M01AC01

INN (Mezinárodní Name):

PIROXICAM

Dávkování:

20MG

Léková forma:

CAPSULE

Složení:

PIROXICAM 20MG

Podání:

ORAL

Jednotky v balení:

100 - 500

Druh předpisu:

Prescription

Terapeutické oblasti:

OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS

Přehled produktů:

Active ingredient group (AIG) number: 0114612001; AHFS:

Stav Autorizace:

CANCELLED POST MARKET

Datum autorizace:

2016-10-28

Charakteristika produktu

                                PRODUCT MONOGRAPH
Pr
pms-PIROXICAM
Piroxicam, USP
10 mg and 20 mg Capsules
10 mg and 20 mg Suppositories
Nonsteroidal Anti-Inflammatory Drug (NSAID)
PHARMASCIENCE INC.
DATE OF REVISION:
6111 Royalmount Avenue
February 17, 2010
Montreal, Quebec
H4P 2T4
CONTROL # 131400
_ _
2
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL
INFORMATION..........................................................3
SUMMARY PRODUCT INFORMATION
.......................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND
PRECAUTIONS..................................................................................5
ADVERSE
REACTIONS..................................................................................................14
DRUG INTERACTIONS
.................................................................................................19
DOSAGE AND ADMINISTRATION
..............................................................................22
OVERDOSAGE
................................................................................................................23
ACTION AND CLINICAL
PHARMACOLOGY.............................................................23
STORAGE AND
STABILITY..........................................................................................24
DOSAGE FORMS, COMPOSITION AND PACKAGING
............................................24
PART II: SCIENTIFIC INFORMATION
................................................................................26
PHARMACEUTICAL
INFORMATION..........................................................................26
CLINICAL TRIALS
..........................................................................................................27
DETAILED PHARMACOLOGY
.....................................................................................27

                                
                                Přečtěte si celý dokument
                                
                            

Dokumenty v jiných jazycích

Charakteristika produktu Charakteristika produktu francouzština 17-02-2010

Vyhledávejte upozornění související s tímto produktem

Zobrazit historii dokumentů